NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: K
Post# of 198
(Total Views: 172)
Posted On: 09/01/2023 4:15:38 PM
NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 and K1 ASRs to Patrol New York-Based Pharmaceutical Facility
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new 7-robot contract with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. The new client subscribed to one K5 ASR assigned to patrol a 4-story garage and six K1-Tower ASRs to monitor building entrances, open areas and parking lots throughout the corporate campus.
The announcement reads, “A secure and resilient pharmaceutical supply chain in the United States is the best means to ensure that U.S. patients and the health care system have access to a consistent and dependable supply of critical medicines. At the top of the supply chain are the pharmaceutical corporate campuses that require a robust, multi-layered safety and security program similar to the one described in a recent Knightscope blog. And according to the National Institutes of Health (‘NIH’), protecting the integrity of that supply chain is critical to providing medications that are free from adulteration (counterfeit, substandard or unapproved medications), making them safe for patient use. Knightscope’s technologies will help safeguard the material and intellectual property under development at this cutting-edge facility as well as the staff who are assisting people lead healthier lives.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced a new 7-robot contract with a publicly traded biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. The new client subscribed to one K5 ASR assigned to patrol a 4-story garage and six K1-Tower ASRs to monitor building entrances, open areas and parking lots throughout the corporate campus.
The announcement reads, “A secure and resilient pharmaceutical supply chain in the United States is the best means to ensure that U.S. patients and the health care system have access to a consistent and dependable supply of critical medicines. At the top of the supply chain are the pharmaceutical corporate campuses that require a robust, multi-layered safety and security program similar to the one described in a recent Knightscope blog. And according to the National Institutes of Health (‘NIH’), protecting the integrity of that supply chain is critical to providing medications that are free from adulteration (counterfeit, substandard or unapproved medications), making them safe for patient use. Knightscope’s technologies will help safeguard the material and intellectual property under development at this cutting-edge facility as well as the staff who are assisting people lead healthier lives.”
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)